Evoke Pharma Inc (NASDAQ:EVOK)

2.39
Delayed Data
As of Apr 20
 +0.0004 / +0.02%
Today’s Change
1.85
Today|||52-Week Range
4.09
+5.77%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues0.000.000.000.00--
 
Operating ExpensesGross Income0.000.000.000.00--
General Expenses13.2M11.8M10.5M11.2M
 
 
 
 
 
Research And Development10.0M8.2M7.0M7.1M
 
 
 
 
 
Total Operating Expenses13.2M11.8M10.5M11.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-13.2M-11.8M-10.5M-11.2M
 
 
 
 
 
Extraordinary Credit0.000.00597.6K0.00
 
 
Extraordinary Charge0.000.000.00-1.0M
 
 
Interest Expense On Debt107.8K303.2K268.0K0.00
 
 
 
 
Other Expenses0.000.00-533.7K0.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-13.2M-12.1M-10.7M-12.2M
 
 
 
 
 
Net Income-13.2M-12.1M-10.7M-12.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS6.0M6.5M9.3M14.9M
 
 
 
 
 
Shares To Calculate EPS Diluted6.0M6.5M9.3M14.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.20-$1.87-$1.15-$0.90
 
 
 
 
 
EPS Diluted-$2.20-$1.87-$1.15-$0.82